Today: 7 February 2026
Subscribe
Browse Category

NASDAQ:DNLI News 10 December 2025 - 29 January 2026

Denali Therapeutics stock price rises as FDA freezes rival Regenxbio’s Hunter syndrome gene therapy trials

Denali Therapeutics stock price rises as FDA freezes rival Regenxbio’s Hunter syndrome gene therapy trials

Denali Therapeutics shares rose 3.7% to $21.62 Thursday after the FDA halted Regenxbio’s gene therapy trials over a brain tumor case, intensifying focus on Denali’s Hunter syndrome drug under FDA review. Investors await Denali’s clinical data update in early February and a regulatory decision by April 5. The iShares Nasdaq Biotechnology ETF was little changed.
29 January 2026
····
US Stock Market Top Losers Today (December 10, 2025): Polestar, AeroVironment, Denali, Uber and AutoZone Tumble After the Bell

US Stock Market Top Losers Today (December 10, 2025): Polestar, AeroVironment, Denali, Uber and AutoZone Tumble After the Bell

Despite a Fed-fueled rally that pushed major US indices toward record highs, a cluster of high‑profile stocks sank sharply on Wednesday. Here’s what drove today’s biggest losers — and what Wall Street is saying next. Market recap: Fed cut fuels rally, but pockets of pain emerge New York — December 10, 2025. Wall Street finished the day higher after the Federal Reserve delivered a widely expected 25‑basis‑point rate cut, its third cut of 2025, taking the federal funds target range down to roughly 3.50%–3.75%.Reuters+2Investopedia+2 The S&P 500 and Dow Jones Industrial Average both advanced and flirted with all‑time highs, while
10 December 2025
········

Stock Market Today

Lucid stock jumps 14% as Dow tops 50,000 — what LCID investors watch next week

Lucid stock jumps 14% as Dow tops 50,000 — what LCID investors watch next week

7 February 2026
Lucid Group shares jumped 14% to $10.86 at Friday’s close, recovering from an 8% drop the previous day. The move followed a broad Wall Street rally that lifted high-volatility stocks. Lucid reported fourth-quarter deliveries of 5,345 vehicles and full-year deliveries of 15,841. Investors await Lucid’s Feb. 24 results for updates on cash and demand.
Go toTop